We're standing by & we can help. It's free and confidential.*
CONTACT THIS PRACTICE
Although the Food and Drug Administration approved surgical mesh for use in pelvic organ prolapse (POP) in 2002, the controversy surrounding its use continues to grow. Doctors often favor this method of POP surgery, claiming it is simpler and less invasive.
However, the FDA and some medical professionals contend that surgical placement of mesh through the vagina may expose patients to greater risk than other surgical options.
In 2002, the FDA approved surgical mesh for POP. Prior to 2002, the FDA had approved surgical mesh for use in stress urinary incontinence (SUI) and hernia repairs. SUI is caused by leakage of urine during moments of physical stress.
In 2008, the FDA issued its first warning regarding surgical mesh for POP. In 2011, the FDA issued an updated warning regarding the use of surgical mesh in POP repairs.
In 2016, the FDA reclassified transvaginal mesh products by designating them as Class III, which generally includes high-risk devices. The FDA also strengthened the approval process requirements for surgical mesh for transvaginal repair of POP.
A POP occurs when a pelvic organ, such as the bladder, drops (“prolapses”) from its normal position and pushes against the walls of the vagina. This can happen if the muscles that hold the pelvic organs in place become weak or stretched from childbirth, surgery, or the aging process.
More than one pelvic organ can drop at the same time. Organs that can be involved in POP include the bladder, uterus, bowel and rectum, or, after a hysterectomy, vaginal vault prolapse. In this case, the vagina collapses in upon itself because of the removal of the uterus.
According to the FDA, although rare, complications did occur. Patients who have had a POP may experience:
Are you suffering from any of these complications resulting from transvaginal mesh surgery? If so, you may be entitled to compensation.
Finding an attorney with a strong record of success can be difficult. In fact, locating a qualified attorney can feel overwhelming. Although an internet search provides more responses than imaginable, you need to ask the right questions to find the legal firm that can best represent your interests. These include asking about the firm’s prior experience and philosophy when working with clients.
Weitz & Luxenberg stands out with our superior results and ability to handle complicated medical lawsuits. In fact, we are one of the largest personal injury and mass tort plaintiffs’ firms and our attorneys successfully represent tens of thousands of individuals.
As a nationally recognized personal injury law firm, Weitz & Luxenberg is committed to helping clients win cases. For more than 25 years, we have dedicated ourselves to holding irresponsible practitioners accountable, and we have won $17 billion for our clients.
We would feel privileged to assist you. For a free consultation and more information about your legal options, please call us at 800-476-6070. If you prefer, you can complete our form, and our client relations representative will contact you shortly.
W&L's Ellen Relkin, as lead counsel in the NJ Rejuvenate and ABG II hip stem litigation, played a key role in negotiating the more than $1 billion settlement. Most qualifying plaintiffs will receive $300,000 or more.
W&L helped negotiate one of the largest mass tort settlements in recent history. More than 300 W&L clients are part of the settlement. Claimants had recalled DePuy ASR hips implanted and removed prior to August 31, 2013.
I'm pleased with the results Weitz & Luxenberg achieved for me in my recently settled case. I was suing a hip-replacement company that tried to act like they did nothing wrong. But the fact is they allowed a defective medical device to go out. That was incredibly wrong. This company needed to learn that their actions were incredibly wrong and that there are consequences to your bad actions.